• 1
    Oliver MF, Heady JA, Morris JN, Cooper J. A cooperative trial in the primary prevention of ischemic heart disease using clofibrate. Br Heart J 1978; 40: 1069118.
  • 2
    Rose G, Shipley MJ. Plasma lipids and mortality: a source of error. Lancet 1980; 1: 5236.
  • 3
    Williams RR, Sorlie PD, Feinleib M, McNamara PM, Kannel WB, Dawber TR. Cancer incidence by levels of cholesterol. JAMA 1981; 245: 24752.
  • 4
    Lilienfeld AM. The Humean fog: cancer and cholesterol. Am J Epidemiol 1981; 114: 14.
  • 5
    Kagan A, McGee DL, Yano K, Rhoads GC, Nomura AMY. Serum cholesterol and mortality in a Japanese-American population: the Honolulu Heart Program. Am J Epidemiol 1981; 114: 1120.
  • 6
    Kozarevic D, McGee DL, Vojdovic N, Gordon T, Racic Z, Zukel W, et al. Serum cholesterol and mortality: The Yugoslavia Cardiovascular Disease Study. Am J Epidemiol 1981; 114: 218.
  • 7
    Garcia-Palmieri MR, Sorlie PD, Costas R Jr., Havlek RJ. An apparent inverse relationship between serum cholesterol and cancer mortality in Puerto Rico. Am J Epidemiol 1981; 114: 2940.
  • 8
    Rose G, Blackburn H, Keys A, Taylor HL, Kannel WB, Paul O, et al. Colon cancer and blood-cholesterol. Lancet 1974; 1: 1813.
  • 9
    Feinleib M. Summary of a workshop on cholesterol and noncar-diovascular disease mortality. New York: Academic Press, 1982: 3607.
  • 10
    Sorlie PD, Feinleib M. The serum cholesterol-cancer relationship: an analysis of time trends in the Framingham Study. J Natl Cancer Inst 1982; 69: 98996.
  • 11
    Sherwin RW, Wentworth DN, Cutler JA, Hulley SB, Kuller LH, Stamler J. Serum cholesterol levels and cancer mortality in 361,662 men screened for the multiple risk factor intervention trial. JAMA 1987; 257: 9437.
  • 12
    Schatzkin A, Taylor PR, Carter CL, Hoover RN, Ziegler RG, Larson DB, et al. Serum cholesterol and cancer in the NHANESI epidemiologic followup study. Lancet 1987; 1: 298301.
  • 13
    Knekt P, Reunanen A, Aromaa A, Heliovaara M, Hakulinen T, Hakama M. Serum cholesterol and risk of cancer in a cohort of 39,000 men and women. J Clin Epidemiol 1988; 41: 51930.
  • 14
    Isles CG, Hole DJ, Gillis CR, Hawthorne VM, Lever AF. Plasma cholesterol, coronary heart disease, and cancer in the Renfrew and Paisley survey. Br Med J 1989; 298: 9204.
  • 15
    Cowan LD, O'Connell DL, Criqui MH, Barrett-Connor E, Bush TL, Wallace RB. Cancer mortality and lipid and lipoprotein levels: the Lipid Research Clinics Program mortality follow-up study. Am J Epidemiol 1990; 131: 46882.
  • 16
    International Collaborative Group. Circulating cholesterol level and risk of death from cancer in men aged 40 to 69 years. JAMA 1982; 248: 28539.
  • 17
    Hiatt RA, Fireman BH. Serum cholesterol and the incidence of cancer in a large cohort. J Chronic Dis 1986; 39: 86170.
  • 18
    Wald NJ, Thompson SG, Law MR, Densen JW, Bailey A. Serum cholesterol and subsequent risk of cancer: results from the BUPA study. Br J Cancer 1989; 59: 9368.
  • 19
    Dawber TR, Meadors GF, Moore FE Jr. Epidemiological approaches to heart disease: the Framingham Study. Am J Public Hearth 1951; 41: 27986.
  • 20
    Gordon T, Moore FE Jr., Shurtleff D, Dawber TR. Some methodologic problems in the long-term study of cardiovascular disease: observations on the Framingham Study. J Chronic Dis 1959; 10: 186206.
  • 21
    Cupples LA, D'Agostino RB. Section 34: Some risk factors related to the annual incidence of cardiovascular disease and death using pooled repeated biennial measurements: Framing-ham Heart Study, 30-year followup. In: KannelWB, WolfPA, GarrisonRJ, editors. The Framingham Study: an epidemiological investigation of cardiovascular disease. Washington, D.C.: United States Government Printing Service Department of Health and Human Services Publication No. [NIH] 87-27031, 1987: 126.
  • 22
    Kreger BE, Splansky GL, Schatzkin A. The cancer experience in the Framingham Heart Study cohort. Cancer 1991; 67: 16.
  • 23
    Abell LL, Levy BB, Brodie BB, Kendall PE. A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. J Biol Chem 1952; 195: 35766.
  • 24
    Gofman JW, For the Joint Technical Group of the Committee of Lipoproteins and Atherosclerosis. Evaluation of serum lipoproteins and cholesterol measurements as predictors of clinical complications of atherosclerosis. Circulation 1956; 14: 691741.
  • 25
    Lewis B. The lipoproteins of plasma. In: LewisB, editor. The hyperlipidaemias: clinical and laboratory practice. Oxford: Blackwell Scientific Publications, 1976: 313.
  • 26
    Wilson PWF, Abbott RD, Castelli WP. High density lipoprotein cholesterol and mortality: the Framingham Heart Study. Arteriosclerosis 1988; 8: 73741.
  • 27
    Cox DR. Regression models and life tables. J R Stat Soc 1972; 34: 187220.
  • 28
    Lew EA, Garfinkel L. Variations in mortality by weight among 750,000 men and women. J Chronic Dis 1979; 32: 56376.
  • 29
    Nomura AMY, Heilbrun LK, Stemmermann GN. Body mass index as a predictor of cancer in men. J Natl Cancer Inst 1985; 74: 31923.
  • 30
    Anderson KM, Wilson PWF, Garrison RJ, Castelli WP. Longitudinal and secular trends in lipoprotein cholesterol measurements in a general population: the Framingham offspring study. Atherosclerosis 1987; 68: 5966.
  • 31
    Slattery ML, Schumacher C, Smith KR, West DW, Abd-Elghany N. Physical activity, diet, and risk of colon cancer in Utah. Am J Epidemiol 1988; 128: 98999.
  • 32
    Gerhardsson M, Floderus B, Norell SE. Physical activity and colon cancer risk. Int J Epidemiol 1988; 17: 7436.
  • 33
    Ballard-Barbash R, Schatzkin A, Albanes D, Schiffman MH, Kreger BE, Kannel WB, et al. Physical activity and risk of large bowel cancer in the Framingham Study. Cancer Res 1990; 50: 36103.
  • 34
    Willett WC, Stampfer MJ, Colditz GA, Rosner BA, Speizer FE. Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women. N Engl J Med 1990; 323: 166472.
  • 35
    Willett W. The search for the causes of breast and colon cancer. Nature 1989; 338: 38994.
  • 36
    Sidney S, Farquhar JW. Cholesterol, cancer, and public health policy. Am J Med 1983; 75: 494508.
  • 37
    Lyon JL, Mahoney AW. Fried food and the risk of colon cancer. Am J Epidemiol 1988; 128: 10006.
  • 38
    Lowenfels AB. Is increased cholesterol excretion the link between low serum cholesterol and colon cancer? Nutr Cancer 1983; 41: 2804.
  • 39
    Cruse P, Lewin M, Clark CG. Dietary cholesterol is cocarcinogenic for human colon cancer. Lancet 1979; 1: 7525.
  • 40
    Harris TB, Nakuc DM, Kleinman JC, Gillum RF, Curb JD, Schatzkin A, et al. Is the serum cholesterol-coronary heart disease relationship modified by activity level in older persons? J Am Geriatr Soc 1991; 39: 74754.